SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161601
Filing Date
2024-06-14
Accepted
2024-06-14 16:07:01
Documents
13
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d855288d8k.htm   iXBRL 8-K 34854
  Complete submission text file 0001193125-24-161601.txt   153302

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyel-20240614.xsd EX-101.SCH 2833
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyel-20240614_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyel-20240614_pre.xml EX-101.PRE 10801
16 EXTRACTED XBRL INSTANCE DOCUMENT d855288d8k_htm.xml XML 3508
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40502 | Film No.: 241044768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)